General Neurosurgeon
About the job
- Must possess an MD and have completed a residency in neurological surgery.
- Must be American Board of Neurological Surgery Board Eligible or Board Certified.
- Must be able to obtain an unrestricted New York Medical License.
- Staff neurosurgery clinics and/or faculty practice as assigned by the Chair and Vice Chair of Neurosurgery.
- Participate in the call schedule and clinically supervise all Neurosurgery patients.
- Perform emergency and elective surgeries.
- Participate in the education of residents, fellows, and students.
- Seek out trials of new treatments for neurological disorders, participate in clinical trials, and identify potential patients for enrollment.
- Perform research as appropriate based on background, experience, and career goals.
City/State:
Bronx, New YorkDepartment:
Department Of NeurosurgeryWork Days:
MON-FRIScheduled Hours:
8 AM-5:30 PMScheduled Daily Hours:
8.5 HOURSGENERAL NEUROSURGEON
THE DEPARTMENT OF NEUROLOGICAL SURGERY
THE POSITION: The Department of Neurological Surgery is seeking dynamic attending with solid clinical and academic experience in General Neurosurgery to join the faculty of Albert Einstein College of Medicine and the Medical Staff of Montefiore Health System. The candidate will have a clinically active practice centered on affiliated Montefiore hospitals located in Westchester and Rockland counties.
At Montefiore Health System, the candidate will:
- Staff neurosurgery clinics and/or faculty practice as assigned by Chair and Vice Chair of Neurosurgery.
- Participate in the call schedule, along with clinical supervision of all Neurosurgery patients. Perform emergency and elective surgeries.
- Involved in the education of residents, fellows, and students.
- Seek out trials of new treatments for neurological disorders, participate in clinical trials, and identify potential patients for enrollment.
- Perform research as appropriate based on background, experience, and career goals.
THE CANDIDATE: The successful candidate must possess an MD and have completed a residency in neurological surgery. Candidates must be ABNS Board Eligible/Board Certified and be able to obtain an unrestricted New York Medical License.
THE HEALTH SYSTEM: Montefiore Health System is the Academic Medical Center and University Hospital for Albert Einstein College of Medicine and is nationally recognized for clinical excellence—breaking new ground in research, training the next generation of healthcare leaders, and delivering science-driven, patient-centered care.
Montefiore is ranked among the top hospitals nationally and regionally by U.S. News & World Report. For more than 100 years Montefiore has been innovating new treatments, new procedures and new approaches to patient care, producing stellar outcomes and raising the bar for medical centers in the region and around the world.
Montefiore welcomes students, faculty and staff from diverse backgrounds who strive to enhance human health in the community and beyond. At the core of their mission is the pursuit of social justice in meeting the healthcare needs of all individuals, including those from underserved communities.
In addition to a competitive salary range of $600,000-$750,000, we offer a comprehensive benefits package including 403(b) with match, LTD, STD, and paid malpractice. This is an outstanding opportunity to join an academically strong, growing and collaborative Division of Neurosurgery in a leading medical school.
Interested individuals should email their CV to Senior Physician Recruiter, William Carpini at [email protected]
Montefiore Health System - Albert Einstein College of Medicine is an Equal Opportunity, Affirmative Action employer. Minorities, women, veterans and individuals with disabilities are encouraged to apply.
Montefiore Medical Center is an equal employment opportunity employer. Montefiore Medical Center will recruit, hire, train, transfer, promote, layoff and discharge associates in all job classifications without regard to their race, color, religion, creed, national origin, alienage or citizenship status, age, gender, actual or presumed disability, history of disability, sexual orientation, gender identity, gender expression, genetic predisposition or carrier status, pregnancy, military status, marital status, or partnership status, or any other characteristic protected by law.About the company
Montefiore Einstein is a major hospital-and-healthcare network in the Bronx that provides medical care through its hospital and outpatient facilities. It combines clinical services with education and research through its affiliation with the Albert Einstein College of Medicine, offering inpatient and outpatient care, diagnostics, specialty treatments, and community health programs. Its care model centers on teams of doctors, nurses, and other clinicians using integrated systems to diagnose, treat, and manage patients. The partnership with Einstein differentiates it by linking patient care with medical teaching and research, enabling clinical trials and innovations to flow from the lab to the bedside. The goal is to deliver comprehensive, high-quality health care, advance medical knowledge through research and education, and improve health outcomes for the communities it serves.
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
$4.9M
Headquarters
New York City, New York
Founded
N/A
Get referred to Montefiore Einstein
See people who can refer or advise you
Simplify's Take
What believers are saying
- June 9, 2026 brought Montefiore One Medical’s first New York specialty-site office in Elmsford.
- May 28, 2026 grants added $8 million for HERO Dads programming and scale.
- Einstein received more than $192 million NIH awards in 2024, sustaining lab momentum.
What critics are saying
- July 2026 AI layoffs cut 12 utilization-review nurses across Moses, Einstein, and Weiler campuses.
- NYSNA filed a class-action grievance after Montefiore’s May 28, 2026 notices.
- Persistent AI labor conflict triggers departures and breaks Montefiore's Bronx service network.
What makes Montefiore Einstein unique
- Albert Einstein College of Medicine feeds Montefiore’s 10-hospital academic engine and NIH-backed research.
- MECCC is NCI-designated, and Ulrich Steidl took leadership on April 7, 2026.
- Amazon One Medical integration gives Montefiore specialty access across Manhattan and Westchester.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Dental Insurance
- Vision Insurance
- Paid Vacation
- Paid Holidays
- Paid Sick Leave
- Health Savings Account/Flexible Spending Account
- Tuition Reimbursement
- Gym Membership
- Life Insurance
- Training Programs
- Conference Attendance Budget
Company News
ATyr Pharma, Inc. announces research collaboration with Albert Einstein College of Medicine and Montefiore Einstein. Published on 10/19/2026 at 01:50 pm EDT S&P Capital IQ aTyr Pharma, Inc. announced a research collaboration with Albert Einstein College of Medicine to further the development and testing of ATYR2810, the Company?s monoclonal antibody that targets the neuropilin-2 (NRP2) receptor. The collaboration will be led by Bang H. Hoang, M.D., Arnold and Madaleine Penner Professor and Co-Director of Orthopaedic Oncology in the Department of Orthopaedic Surgery at Montefiore Einstein. Dr. Hoang?s research focuses on the pathophysiology and molecular mechanisms of bone and soft tissue cancer, including evaluating the role of NRP2 in pediatric bone cancers such as osteosarcoma. ATYR2810 has demonstrated anti-tumor effects in multiple preclinical models, including non-small cell lung cancer, triple-negative breast cancer, renal cell carcinoma and glioblastoma. These findings have been presented at scientific conferences, including the American Academy of Cancer Research, and published in a landmark publication in Science Translational Medicine. (C) S&P Capital IQ - 2026
Newly established cancer leadership roles bring promise to the future of research and care. Oct 15, 2026, 11:20 ET Montefiore Einstein Comprehensive Cancer Center Appoints Senior Leaders to Advance Research and Programs Spanning Basic, Translational, Clinical, and Population Science BRONX, N.Y., Oct. 15, 2026 /PRNewswire/ - Ulrich Steidl, M.D., Ph.D., has finalized his Montefiore Einstein Comprehensive Cancer Center (MECCC) senior leadership team, just six months after stepping into the role of MECCC Director and Vice President of Cancer Medicine at Montefiore Einstein. "Today marks a new chapter as we elevate elite colleagues who have significant research accomplishments and leadership experience to principal posts at MECCC," said Dr. Steidl. "They are recognized "all-stars" in their fields, and together, working at one of the nation's top cancer centers, we will move the needle in not just helping people survive advanced cancers but identifying the factors that drive certain cancers from occurring in the first place." "All-Stars" in Cancer Research & Familiar Faces to the Bronx Community * Amit K. Verma, M.D., M.B.B.S., who was named Chair, Medical Oncology at Montefiore Einstein earlier this year, moved from Associate Director to Deputy Director of MECCC. Dr. Verma is a leader in the study and treatment of myeloid malignancies, such as myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), and Dr. Verma was part of the team that first defined stem cell alterations in MDS and AML. He also led research that discovered the key role of several signaling pathways that are critical to the development of MDS. These findings directly resulted in an FDA-approved novel therapy for MDS. Most recently, Dr. Verma earned an "All-Star" Grant from the V Foundation for his ability to drive transformative projects that can significantly advance cancer research and treatment. He was also elected to the Association of American Physicians (AAP), an honor extended to physicians with outstanding credentials in basic or translational biomedical research. * Julio A. Aguirre-Ghiso, Ph.D., is now Associate Director, Basic Science. Dr. Aguirre-Ghiso, who also serves as Director of MECCC's Cancer Dormancy Institute, is an internationally recognized cancer biologist who recently earned the Metastasis Research Society's highest honor for his substantial advancements in understanding cancer metastasis. He has helped lead a major shift in the cancer biology field by investigating how cancer cells hibernate undetected for long periods of time and what causes them to suddenly awaken to seed deadly, treatment-resistant metastases. He brings his deep scientific expertise in cancer biology and natural curiosity to help stimulate tomorrow's medical breakthroughs. * Marina Konopleva M.D., Ph.D., now Associate Director, Translational Science, is also Co-Director of the Blood Cancer Institute and Director of the Leukemia Program at Montefiore Einstein. She is internationally recognized for her transformational research on proteins that can help leukemia cells evade their natural death signals and how to target these same proteins to make cancer cells more vulnerable to treatment. Her discoveries and translational research have had clinical practice-changing impact in the treatment of myeloid leukemias and other cancers, and led to FDA approval of novel cell death-stimulating drugs. Dr. Konopleva is an elected member of the AAP and has been selected as the recipient of the highly prestigious 2026 Ernest Beutler Prize in Clinical Science by the American Society of Hematology. She will continue spearheading efforts to turn basic laboratory discoveries into clinical treatments that can advance the health of MECCC's patients. Community Engagement at the Forefront Dr. Steidl and his team have also developed a senior leadership position to strengthen research on associations between environmental exposures, health related social needs, and cancer health outcomes. H. Dean Hosgood, Ph.D., Co-Leader of MECCC's Cancer Epidemiology Prevention & Control Program and now Associate Director for Population and Community Sciences has been appointed to lead this effort. Dr. Hosgood is formally trained in environmental epidemiology, cancer epidemiology, and molecular epidemiology. He currently leads a global consortium to investigate how indoor air pollutants - caused from the burning of coal or wood for heating and cooking - are associated with lung cancer mortality and result in an increased risk for other cancers. His research on the interactions between genetics and environmental exposures have appeared in more than 250 peer-reviewed publications. Rounding out the impressive list, Wenjun Guo, Ph.D., will now serve as Co-Leader of the Tumor Microenvironment & Metastasis program, alongside Maja H. Oktay, M.D., Ph.D., and Dr. Aguirre-Ghiso, Ph.D. Aditi Shastri, M.D., has joined Steven Almo, Ph.D., and Evripidis Gavathiotis, Ph.D., as co-leader of MECCC's Cancer Therapeutics Program, developing precision drugs and cellular therapies. For more than 50 years, MECCC has been at the forefront of care and community engagement with novel research and transdisciplinary initiatives, including its Tumor Microenvironment and Metastasis, Stem Cell and Cancer Biology, Cancer Therapeutics, and Cancer Epidemiology, Prevention and Control programs. MECCC patients also benefit from services like its nationally lauded Bronx Oncology Living Daily program which supports patients and families impacted by cancer through peer navigators as well as wellness workshops like yoga, reiki, and creative arts. About Montefiore Einstein Comprehensive Cancer Center Montefiore Einstein Comprehensive Cancer Center (MECCC) is a National Cancer Institute (NCI)-designated comprehensive cancer center and a national leader in cancer research and care located in the Bronx, N.Y. MECCC combines the exceptional science of Albert Einstein College of Medicine with the multidisciplinary and team-based approach to cancer clinical care at Montefiore Health System. Founded in 1971 and an NCI-designated cancer center since 1972, MECCC is redefining excellence in cancer research, clinical care, education and training, and community outreach and engagement. Its mission is to reduce the burden of cancer for all. SOURCE Montefiore Einstein Comprehensive Cancer Center
Montefiore Einstein presents the newly renovated labor and delivery unit at Jack D. Weiler Hospital. Oct 15, 2026, 07:02 ET The project was funded with $9.68 million from the New York State Health Care Facility Transformation Program BRONX, N.Y., October 15, 2026 /PRNewswire-HISPANIC PR WIRE/ - Various elected officials and members of Montefiore Einstein staff had the honor of presenting the newly renovated labor and delivery unit at Jack D. Weiler Hospital. The Weiler Maternal-Infant Unit - located on the sixth floor of 1825 Eastchester Road and funded through a $9.68 million grant from the New York State Health Care Facility Transformation Program - features a reorganization of workflows and infrastructure improvements in the labor and delivery rooms, the obstetric surgical area, and the triage and waiting areas. "Our hospital is the only regional perinatal center in the Bronx and cares for the highest-risk pregnancies throughout the Bronx and parts of Queens," explains Angela Gonzalez-Perez, MPA, FACHE, Vice President of Operations and Executive Director of Jack D. Weiler Hospital. "For us, it was a priority to ensure that our patients enjoyed a warm and welcoming environment where they could receive the best possible care. Thanks to the enormous support of New York State, this newly renovated space is the physical expression of our vision: to be a top-tier academic medical center that transforms health and improves people's lives." Better experiences for Bronx patients This modern unit incorporates state-of-the-art improvements in the labor and delivery rooms, which now have private bathrooms; a reorganized clinical team station and workflow; a modernized triage area with six triage stations and one assessment station, and a modernized obstetric surgical area with a post-anesthesia care unit (PACU) exclusively for cesarean sections equipped with four bays, as well as improvements in the three operating rooms of the labor and delivery unit. In addition, lighting throughout the unit has been improved to provide a warmer and more relaxing environment. Montefiore Einstein has also invested in remote monitoring instruments to support both patients and clinical teams, and offers new food options to improve the patient experience. Under the leadership of Mark H. Einstein, M.D., M.S. - who in 2024 held the Chella and Moise Safra Chair, as well as the chairmanship of the Department of Obstetrics, Gynecology and Women's Health - 26 new physicians specializing in areas such as critical care obstetrics, adolescent medicine, and oncofertility have been brought on board, along with advanced practice nurses (NPs) and physician assistants, to strengthen care. In addition, services such as universal hospital depression screening; collaborative reproductive psychiatry care; a postpartum outpatient clinic specializing in people with medically complex or high-risk pregnancies, and a maternal cardiology program continue to be strengthened. Dr. Einstein's leadership team has played a fundamental role in the design of this new unit. "Thanks to the new technological improvements and the reorganization of workflows, we are better prepared to handle the most complex cases, and to do so in a renovated, attractive, and welcoming environment for families," says Rodney Wright, M.D., Vice President of Obstetrics. "I am enormously proud to present this unit and to continue expanding our department and support services for our patients and their loved ones," says Mark H. Einstein, M.D., M.S., who is also a professor of Obstetrics, Gynecology and Women's Health (Gynecologic Oncology) at Albert Einstein College of Medicine. The renovation of the Labor and Delivery Unit was carried out in phases, which avoided having to interrupt patient care. Five of the six planned phases have already been completed. The last phase, expected to be completed in early 2027, will include the renovation of the last two labor and delivery rooms and the modernization of a service elevator located at the rear. Source Montefiore Health System
Top left menu. Nyack, NY, August 12, 2026 - Montefiore Nyack Hospital has earned the Leapfrog Full Transparency Badge, recognizing the hospital's commitment to publicly reporting information about patient safety and quality through the annual Leapfrog Hospital Survey. The Full Transparency Badge is awarded to hospitals that complete, affirm, and submit all sections of the Leapfrog Hospital Survey, one of the nation's leading voluntary reporting programs focused on patient safety, quality, and transparency. Trust begins with transparency, said Anthony Matejicka, DO, MPH, FACP, vice president, chief medical officer at Montefiore Nyack Hospital. Montefiore Nyack is deeply honored to be recognized by The Leapfrog Group for its commitment to sharing patient safety information and quality data openly with the community. This is not the first time The Leapfrog Group recognized Montefiore Nyack Hospital. Earlier this spring, The Leapfrog Group awarded the hospital with an A safety grade. In addition, the hospital earned accolades from US News & World Report as one of the best Home Care Agencies in 2026; and most recently, The American Heart Association presented the hospital with a Get With The Guidelines(R)- Stroke Gold Plus award for demonstrating its commitment to delivering evidence-based, life-saving stroke care. Castle Connolly also named Montefiore Nyack Hospital as a leader in patient care, earning a spot on the organization's Top Hospitals list for a New York State Procedure Award for General Surgery. Montefiore Nyack applaud Montefiore Nyack Hospital for its commitment to transparency, said Leah Binder, president and CEO of The Leapfrog Group. Transparency is one of the most powerful drivers of improvement in health care. By fully participating in the Leapfrog Hospital Survey, Montefiore Nyack Hospital is helping patients and families access meaningful information about the safety and quality of their care. The Leapfrog Full Transparency Badge appears on Leapfrog's public ratings website and identifies hospitals that have committed to openly sharing information about their performance. About Montefiore Nyack Hospital Montefiore Nyack Hospital is a 375-bed community acute care medical and surgical hospital founded in 1895. Its mission is to provide competent, innovative, and accessible emergency and acute care services to the residents of Rockland County, NY, and its surrounding areas. It is a member of Montefiore Health System and a partner with Albert Einstein College of Medicine and Touro College of Osteopathic Medicine, providing clinical rotations to medical students. To learn more, visit www.montefiorenyack.org; follow Montefiore Nyack on Facebook, X, LinkedIn, and Instagram; view Montefiore Nyack on YouTube. About The Leapfrog Group Founded in 2000 by large employers and other purchasers, The Leapfrog Group is an independent national nonprofit organization driving a movement for patient safety and transparency. Leapfrog collects, analyzes, and publicly reports data on hospital and ambulatory surgery center performance to help patients, purchasers, and other stakeholders make informed health care decisions. Leapfrog's flagship initiatives include the Leapfrog Hospital Safety Grade, a biannual letter grade focused exclusively on hospital safety, and the Leapfrog Hospital Survey, a voluntary survey that publicly reports hospital performance on patient safety and quality measures. Leapfrog's ratings and reports are peer-reviewed, fully transparent and free to the public. For more from Leapfrog, follow Montefiore Nyack on Twitter, LinkedIn, Facebook and Instagram and sign up for its newsletter.
Top left menu. Nyack, NY, August 12, 2026 - Montefiore Nyack Hospital has been named among U.S. News & World Report's 2026-2027 Best Hospitals edition as a High Performing hospital for Heart Failure, Kidney Failure, Leukemia, Lymphoma & Myeloma, and Pneumonia. This is the highest distinction a hospital can earn as part of U.S. News' Best Hospitals Procedures & Conditions ratings. Fewer than half of the thousands of hospitals evaluated earned a 'High Performing' designation in the types of care evaluated by U.S. News. Earlier this year, Montefiore Nyack Hospital also received designation as a High Performing Hospital for Maternity Care for the third year in a row and a Best Home Health Care Agency in this inaugural ranking. U.S. News' annual Procedures & Conditions ratings are designed to assist patients and their health care providers in making informed decisions about where to receive care for challenging health conditions or elective procedures. When a patient needs specialty care, they should take comfort in knowing that it can be provided at the highest level right here in its community, said Mark E. Geller, MD, FACR, president and CEO of Montefiore Nyack. At Montefiore Nyack Hospital, Montefiore Nyack pride ourselves on providing a wide range of exceptional clinical services while keeping patient experience at the center of everything Montefiore Nyack do. This recognition from U.S. News & World Report reflects its ongoing commitment to delivering high-quality care close to home, and Montefiore Nyack is honored to be recognized among its Best Hospitals. When patients face a major surgery or a chronic medical condition, having access to clear, quality data is vital, said U.S. News' Managing Editor and Chief of Health Analysis Ben Harder. A 'High Performing' rating means that Montefiore Nyack Hospital outperformed a national threshold, giving families a reliable starting point as they consult with their doctors to choose the best place for care. U.S. News evaluated nearly 4,500 hospitals across 14 adult specialties and 23 procedures and conditions; less than half earned recognition in any of those 37 areas of care. To determine the Best Hospitals, U.S. News analyzed each hospital's performance based on objective measures such as risk-adjusted mortality rates, preventable complications and patient experience. The Best Hospitals Specialty rankings methodology and Procedures & Conditions ratings methodology measure patient outcomes using data from over 800 million records of patient care. About Montefiore Nyack Hospital Montefiore Nyack Hospital is a 375-bed community acute care medical and surgical hospital founded in 1895. Its mission is to provide competent, innovative, and accessible emergency and acute care services to the residents of Rockland County, NY, and its surrounding areas. It is a member of Montefiore Health System and a partner with Albert Einstein College of Medicine and Touro College of Osteopathic Medicine, providing clinical rotations to medical students. To learn more, visit www.montefiorenyack.org; follow Montefiore Nyack on Facebook, X, LinkedIn, and Instagram; view Montefiore Nyack on YouTube. About U.S. News & World Report U.S. News & World Report is the global leader for journalism that empowers consumers, citizens, business leaders and policy officials to make confident decisions in all aspects of their lives and communities. A multifaceted media company, U.S. News provides unbiased rankings, independent reporting and analysis, and consumer advice to millions of people on USNews.com each month. A pillar in Washington for more than 90 years, U.S. News is the trusted home for in-depth and exclusive insights on education, health, politics, the economy, insurance, personal finance, travel, automobiles, real estate, careers and consumer products and services.